Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum proteome predicts virological response in chronic hepatitis C genotype 1b patients treated with pegylated interferon plus ribavirin.

Journal of the Formosan Medical Association = Taiwan yi zhi - 1 Jul 2015

Yen Yi-Hao, Wang Jyh-Chwan, Hung Chao-Hung, Lu Sheng-Nan, Wang Jing-Houng, Hu Tsung-Hui, Kee Kwong-Ming, Hsiao Chang-Chun, Lee Chuan-Mo

Abstract excerpt

BACKGROUND/PURPOSE: Whether serum proteome changes can predict treatment response in chronic hepatitis C remains unclear. We investigated the association between serum proteome changes and virological responses in chronic hepatitis C virus genotype 1b (HCV-1b) patients treated with pegylated interferon (PegIFN) plus ribavirin (RBV). METHODS: One hundred and thirty-six HCV-1b patients who had completed a course of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Therapy, Combination
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Mass Spectrometry

Share to Multivariate Analysis

Share to Proteome

Share to Ribavirin

Share to Taiwan

Source

Identifiers

PMID: 23810703
DOI: 10.1016/j.jfma.2013.04.013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum proteome predicts virological response in chronic hepatitis C genotype 1b patients treated with pegylated interferon plus ribavirin.PMID 23810703Read ↗

High predictive accuracy of an unbiased proteomic profile for sustained virologic response in chronic hepatitis C patients.Semantic proximity Read ↗

Using Stepwise Pharmacogenomics and Proteomics to Predict Hepatitis C Treatment Response in Difficult to Treat Patient Populations.Semantic proximity Read ↗

Characterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C.Semantic proximity Read ↗

Prediction of prognostic biomarkers for interferon-based therapy to hepatitis C virus patients: a meta-analysis of the NS5A protein in subtypes 1a, 1b, and 3a.Semantic proximity Read ↗

Proteomic Signatures of Hepatitis B Virus Mutations Reveal Genotype-Specific Host Responses and Biomarker CandidatesSemantic proximity Read ↗

Comparative Analysis of Serum Proteins Between Hepatitis B Virus Genotypes B and C Infection by DIA-Based Quantitative ProteomicsSemantic proximity Read ↗

Plasma interferon-gamma-inducible protein-10 can predict virologic response to hepatitis C virus therapy in HIV/HCV-coinfected patients with HCV genotype 1.Semantic proximity Read ↗

Epitope-based therapeutic targets in HCV genotype 1 non-structural proteins: a novel strategy to combat emerging drug resistance.Semantic proximity Read ↗

Hepatitis C virus genotype 1: how genetic variability of the core protein affects the response to pegylated-interferon and ribavirin therapy.Semantic proximity Read ↗

Gene Expression Profiling To Predict and Assess the Consequences of Therapy-Induced Virus Eradication in Chronic Hepatitis C Virus InfectionSemantic proximity Read ↗

Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis C.Semantic proximity Read ↗

Early decline of the HCV core antigen can predict SVR in patients with HCV treated by Pegylated interferon plus ribavirin combination therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.